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Background
Left ventricular hypertrophy (LVH) is a common presenta-
tion among hypertensive patients. Micro-RNAs (miRNAs)
have been proven to show reproducible dysregulations in
hypertrophied cardiac tissues. Three miRNAs, miR-133,
miR-155, and miR-195 were used in the study to elucidate
the miRNA expression anomaly in heart diseases.
MiR-133 and miR-195 have been reported as two highly
expressed miRNAs in normal mouse heart tissue. The aim
of this study is to observe the relationship of the levels of
circulating miR-133, miR-155 and miR-195, with the phe-
notype of cardiac hypertrophy among LVH patients and
normal controls.
Materials and methods
Forty-four hypertensive patients and 26 unrelated healthy
individuals were selected and their peripheral blood were
collected through venipuncture. Total RNA was then
extracted and reverse transcribed into cDNA. The cDNA
templates were subjected to quantitative real time poly-
merase chain reaction. The expression levels of miR-133,
miR-155, and miR-195 were compared between the
patient and the control groups. Echocardiograms were
also obtained from all subjects to evaluate the condition of
the heart.
Results
The delta CT means of miR-133, miR-155 and miR-195
were 17.427, 13.343, and 9.406, respectively for the control
group. However, the delta CT means of miR-133, miR-155
and miR-195 for the patient group were 18.078, 13.8427,
and 10.2295, respectively. The expression levels of
miR-133, miR-155 and miR-195 were found to be signifi-
cantly down-regulated in patients with p values of 0.0306,
0.03567, and 0.0105, respectively.
Conclusions
Our data show that the down-regulated expression of
miR-133 and miR-155 in the presence of LVH reported in
previous tissue and in vivo studies is also reflected in the
circulating levels. Interestingly, the pattern of dysregula-
tion observed in circulatory miR-195 expression level in
hypertrophic patients disagrees with published in vivo stu-
dies. A larger sample size could prove useful in the valida-
tion of miR-133, miR-155 and miR-195 as biomarkers of
LVH development. Further studies to illuminate the tar-
gets and mechanisms involved would be beneficial in the
efforts to reverse this debilitating condition.
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